Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dermaprazole for Radiation Dermatitis in Breast Cancer
NCT05269160Phase 2Terminated
- Sponsor
- Baylor College of Medicine
- Start
- Apr 2023
- Primary completion
- Jun 2023
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of Dermaprazole in radiation dermatitis, sponsored by Baylor College of Medicine. Started Apr 2023; status: terminated.
02
Drugs
Dermaprazole
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT05269160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05269160.